Chana discusses her role at the FDA, how it functions and answers questions on topical issues.

Episode 257: Chana Weinstock from the FDA 

Mat Galski discusses the past, present and future of ctDNA in this disease.

Episode 256: ctDNA in urothelial studies. 

Walt Stadler gives tips to writing papers and navigating the review process.

Episode 255: How to get an academic paper accepted 

Laurence Albiges

Laurence Albiges discusses biomarker studies, new combinations and new therapies which were covered in the KCRS23 meeting in the ‘new studies' session.

Laurence Albiges discusses biomarker studies, new combinations and new therapies which were covered in the KCRS23 meeting in the ‘new studies' session.

Episode 254: New RCC studies at KCRS 2023 with Laurence Albiges 

Rachel Giles (chair of IKCC) describes her data from patients on these topics in RCC

Episode 253: Patients' perspectives on adjuvant and 1st line RCC 

Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and BRCA1/2 occurs

Episode 252: Talazoparib and its FDA approval in CRPC 

Meredith Regan and David McDermott try to make sense of it all but are unexpectedly interrupted. PFS2 and TFS are covered along with previously discussed endpoints.

Episode 251: Final part of VEGF/TKI vs IPI/NIVO discussion 

After the discussion with Mike Atkins, Bob Motzer gives his perspective of the 1st line renal cancer situation .

Episode 250: Bob Motzer discusses IPI/Nivo vs VEGF/PD1 

Prompted by a question during the oral kidney cancer session at ASCO, Mike Atkins explains his position. Disagreement prevails.

Episode 249: ASCO 2023 emergency podcast IPI/NIVO vs VEGF/PD1 in kidney cancer 

Silke Gillessen joins Brian and Tom for a quick round up.

Episode 248: ASCO23 GU highlights 

Broadcasting the latest developments in GU cancer

This is a great series with insightful analysis of the data from recent clinical trials.

Great discussion!

The Uromigos

Front

Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment options

Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment options

Episode 4: Treatment Choices in Front Line Advanced Renal Cancer

Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them

Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them

Episode 1: Introduction to Uromigos Podcasts

Tian Zhang

Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial.

Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial.

Episode 25: Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial

Chuck Drake and Doug Johnson discuss possible risk benefits of immune checkpoint inhibitors during the COVID-19 pandemic. 

Chuck Drake and Doug Johnson discuss possible risk benefits of immune checkpoint inhibitors during the COVID-19 pandemic.

Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer 

Mike Morris

Mike Morris presents the findings in his prospective study. 

Mike Morris presents the findings in his prospective study.

Episode 29: PSMA PET at ASCO 2020 with Mike Morris 

The Uromigos can’t agree on how to approach COVID-infected GU cancer patients who need systematic treatment.

Episode 20: Treating GU Cancer Patients with acute COVID-19 Infection 

Chris Sweeney explains why the trial was negative and answers some of the questions.

Episode 23: Atezolizumab and Enzalutamide versus Enzalutamide Prostate Cancer 

Marina Garassino and Leora Horn discuss their AACR study of COVID-19 in lung cancer.

Marina Garassino and Leora Horn discuss their AACR study of COVID-19 in lung cancer.

Episode 24: A Study of COVID-19 in Lung Cancer Shows High Mortality 

Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco. 

Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco.

Episode 5: Renal Highlights from ASCO GU 2020

Kaushik Amancherla and Javid Moslehi discuss the link of COVID-19 and cardiovascular disease. Professor Tom Powles and Dr. Brian Rini struggle to keep up.

Episode 22: COVID-19 and Cardiovascular Disease 

Monty Pal

Professor Monty Pal discusses non-clear cell renal cancer while Dr. Brian Rini gets irritated by background interruptions. 

Professor Monty Pal discusses non-clear cell renal cancer while Dr. Brian Rini gets irritated by background interruptions.

Episode 19: Professor Monty Pal discusses the treatment of non-clear cell renal cancer 

A discussion with doctors from the Fred Hutchinson Cancer Center in Seattle about COVID-19.

Episode 12: COVID-19 in Cancer Patients - The Seattle Experience 

Dr. David Boulware discusses existing data and ongoing prophylaxis studies.

Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials 

Nick Mark

Dr. Brian Rini and Professor Tom Powles discuss the data and ongoing studies with the IL-6 antibody tocilizumab.

Dr. Brian Rini and Professor Tom Powles discuss the data and ongoing studies with the IL-6 antibody tocilizumab.

Episode 14: A Discussion about Tocilizumab and COVID-19 with Dr. Nick Mark from Seattle 

Professor Nick Mark discusses the latest data on drug treatments and trials for COVID-19.

Episode 16: Treatments and Trials for COVID-19

Dena Battle presents a 500-patient survey on issues around COVID-19. Professor Tom Powles and Dr. Brian Rini attempt to address the issues raised.

Episode 18: COVID-19: Addressing Renal Cancer Patients’ Concerns 

Joaquim Bellmunt talks about management of muscle invasive bladder cancer prior to the Atezolizumab adjuvant data at ASCO20. 

Joaquim Bellmunt talks about management of muscle invasive bladder cancer prior to the Atezolizumab adjuvant data at ASCO20.

Episode 26: Joaquim Bellmunt and Muscle Invasive Bladder Cancer prior to ASCO 2020

Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen. 

Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen.

Episode 8: COVID-19 and Cancer Patients 

Jeremy Warner

Jeremy Warner summarises the recent Lancet paper describing the outcome of cancer patients with COVID-19. 

Jeremy Warner summarises the recent Lancet paper describing the outcome of cancer patients with COVID-19.

Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19)

The Uromigos discuss the practicalities in surgery for bladder cancer in the era of COVID-19 with Betsy Plimack (Fox Chase Cancer Center, Philadelphia)

Episode 15: COVID-19 and Bladder Cancer Surgery 

The best podcast episodes on Startups. For anyone working in a startup, or anyone interested in the incredible stories behind how people built companies like Instagram, and Facebook. Offering both practical advice and insights, as well as the stories for how many of the biggest startups got to where they are today. Add episodes you're interested into your queue below!

OwlTail

Best Startups Podcasts

The best philosophy podcast episodes. Asking questions about how to live a better life, what it means to be and do good, to the idea of God. This topic includes episodes that bring about important questions that everyone should be asking themselves. Add episodes you're interested into your queue below!